Study to Evaluate SBRT for EGFR Mutant NSCLC Patients Receiving Osimertinib (CULTRO)

Conditions

• EGF-R Positive Non-Small Cell Lung Cancer
• Non Small Cell Lung Cancer
• EGFR Exon 19 Deletion
• EGFR Exon 21 Mutation
• EGFR G719X

Interventions

• RADIATION: Stereotactic Body Radiation Therapy SBRT

Sponsor

Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo